Literature DB >> 18043208

Levosimendan in cardiogenic shock: the magic drug for every patient?

Peter Smetana, Alexander Geppert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18043208     DOI： 10.1097/01.CCM.0000288090.16688.B1

Source DB:  PubMed          Journal:  Crit Care Med        ISSN： 0090-3493            Impact factor:   7.598


× No keyword cloud information.
  2 in total

1.  Understanding the differences among inotropes.

Authors:  Kurt Lenz; Fritz Firlinger; Robert Buder
Journal:  Intensive Care Med       Date:  2015-06-11       Impact factor: 17.440

2.  Rationale and design of a randomized, double-blind, placebo controlled multicenter trial to study efficacy, security, and long term effects of intermittent repeated levosimendan administration in patients with advanced heart failure: LAICA study.

Authors:  Martín J García-González; Manuel de Mora-Martín; Silvia López-Fernández; Javier López-Díaz; Manuel Martínez-Sellés; José Romero-García; Marco Cordero; Antonio Lara-Padrón; Francisco Marrero-Rodríguez; M del Mar García-Saiz; Ana Aldea-Perona
Journal:  Cardiovasc Drugs Ther       Date:  2013-12       Impact factor: 3.727
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.